Chemotherapeutic management of the hormone-secreting endocrine malignancies.
D007516:Adenoma, Islet Cell / Q000175:diagnosis* / Q000188:drug therapy*; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D000616:Aminoglutethimide / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002074:Butanones / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000188:drug therapy*; D003981:Diazoxide / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology; D007329:Insulin Antagonists; D007684:Kidney Tubules / Q000187:drug effects; D008797:Metyrapone / Q000627:therapeutic use; D008939:Mitotane / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010673:Pheochromocytoma / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D012702:Serotonin Antagonists; D013311:Streptozocin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000814:Aniline Compounds; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D002074:Butanones; D007329:Insulin Antagonists; D011743:Pyrimidines; D011758:Pyrroles; D011759:Pyrrolidines; D012263:Ribonucleosides; D012702:Serotonin Antagonists; D000616:Aminoglutethimide; D013311:Streptozocin; D008939:Mitotane; D003981:Diazoxide; D008797:Metyrapone